Skip to main content

Policy/Advocacy

The Cocaine, Meth & Stimulant Summit closed with two state perspectives on how faith communities can bolster responses to drug crises.
Organizations representing addiction medicine and recovery advocacy are among the supporters of proposed federal legislation to standardize prescriber training in managing substance use disorders.
A task force of the Association of Schools & Programs of Public Health believes that if a comprehensive opioid-fighting initiative that includes all treatment and harm reduction approaches isn't launched, overdose deaths will continue to climb.
The president and vice president of the American Society of Addiction Medicine (ASAM) write that an incomplete understanding of addiction has given rise to misguided policies.
The FDA announced it is now receiving public comments on the development and evaluation of abuse-deterrent formulations of central nervous system stimulants and whether such products could play a role in addressing public health concerns over prescription stimulant misuse.
Back to Top